WuXi Oncology and Immuno-Oncology Services
Integrated Oncology and Immuno-oncology Platform to Enable Translational Science from Drug Discovery to Clinical Biomarker
Oncology Services
- CRISPR/Cas9 Gene Editing
- In Vitro Assay and HTS
- Tumor models
- Tumor Cell Panel and Screening
- Immunology and Immuno-oncology Platform
- Clinical Biomarker
Immunology Services
- Ligand-receptor binding assays
- Cellular functional assays
- Assays for innate immunity pathways: macrophage, MDSC, NK, DC, mast cell
- Adaptive immunity: T, B cell
- 40+ established autoimmune and inflammation disease models
Rare Disease Services | Large Animal Services
Oncology-Immunology-Services
Related Content
In recent years, bispecific antibodies (BsAbs) have emerged as a novel strategy in tumor immunotherapy. BsAbs combine two distinct antigen...
VIEW RESOURCEWuXi AppTec provides integrated and cost-effective services for: Polyclonal and monoclonal antibodies Anti-drug antibodies (ADA), host cell protein (HCP) antibodies,...
VIEW RESOURCE